肿瘤学中文核心期刊高被引论文分析

Analysis of highly cited papers in Chinese core journals of oncology

目的探讨入选2017年版《中文核心期刊要目总览》的10种肿瘤学期刊高被引论文的文献计量学特征。方法采用文献计量法分析10种肿瘤学核心期刊刊载的高被引论文被引情况、基金资助、栏目分布、作者地区分布、作者及机构合作等特征。结果2015-2019年10种肿瘤学核心期刊发表论文14017篇,被引论文9694篇(69.16%),高被引论文248篇。高被引论文的作者主要分布在中国30个地区,其中发表高被引论文数量排在前5位的地区分别是北京市、上海市、天津市、四川省和广东省,基金资助以国家级为主,作者以≥7人合作为主;篇均被引频次居前3位的高被引论文来源于“临床流行病学”“指南与共识”和“专家论坛”栏目。结论高被引论文的地区、机构分布不均;我国中文核心期刊应积极开拓优秀原创性科学研究和技术创新类稿源,进一步提升期刊的国际竞争力。

Objective To investigate the bibliometric characteristics of highly cited papers in ten Chinese core journals(2017 edition).Methods The citation status,fund assistance,column distribution,regional distribution,author and organization cooperation and other characteristics of highly cited papers published in ten oncology core journals were analyzed using bibliometric method.Results 14017 papers were published in ten oncology core journals from 2015 to 2019 while 9694 papers(69.16%)were cited,and 248 papers were highly cited.The authors of highly cited papers are mainly distributed in 30 regions of China,of which the top five regions are Beijing,Shanghai,Tianjin,Guangdong Province and Sichuan Province.The funding of highly cited papers is mainly at the national level,and the authors mainly cooperate with more than 7 persons.The top 2 highly cited papers are from the column of“guidelines and consensus”and“expert forum”.Conclusion The distribution of highly cited papers in different regions and institutions is uneven;Chinese core journals should actively explore the source of original scientific research and technological innovation in order to improve journal international competitiveness.